IN2013MU02366A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02366A
IN2013MU02366A IN2366MU2013A IN2013MU02366A IN 2013MU02366 A IN2013MU02366 A IN 2013MU02366A IN 2366MU2013 A IN2366MU2013 A IN 2366MU2013A IN 2013MU02366 A IN2013MU02366 A IN 2013MU02366A
Authority
IN
India
Prior art keywords
relates
present
agomelatine
effective amount
time period
Prior art date
Application number
Other languages
English (en)
Inventor
Verma Sumitkumar
Chhunchha Alpesh
Dhavale Satyavan
Sehgal Ashish
Original Assignee
Astron Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astron Res Ltd filed Critical Astron Res Ltd
Priority to IN2366MU2013 priority Critical patent/IN2013MU02366A/en
Publication of IN2013MU02366A publication Critical patent/IN2013MU02366A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2366MU2013 2013-07-15 2013-07-15 IN2013MU02366A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2366MU2013 IN2013MU02366A (zh) 2013-07-15 2013-07-15

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2366MU2013 IN2013MU02366A (zh) 2013-07-15 2013-07-15

Publications (1)

Publication Number Publication Date
IN2013MU02366A true IN2013MU02366A (zh) 2015-06-19

Family

ID=54396599

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2366MU2013 IN2013MU02366A (zh) 2013-07-15 2013-07-15

Country Status (1)

Country Link
IN (1) IN2013MU02366A (zh)

Similar Documents

Publication Publication Date Title
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MX2021000550A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.
EA201690962A1 (ru) Составы
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015501096A1 (en) Composition for immediate and extended release
MX2018000419A (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor.
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
MX2016001422A (es) Composicion farmaceutica de fingolimod.
MY179509A (en) Piperazine derivatives having multimodal activity against pain
MX2015011536A (es) Nuevos antagonistas de receptores trpa1 de sulfamidas.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
UA117154C2 (uk) Антагоністи s1p3
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
BR112016007031A8 (pt) composição farmacêutica oral sólida, processo para preparar a composição farmacêutica oral sólida, e uso de uma composição farcêutica oral sólida
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
PH12020500120A1 (en) Pharmaceutical compositions
IN2013MU02366A (zh)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
TN2015000524A1 (en) Pharmaceutical compositions
IN2013MU03428A (zh)